EGFR and urinary bladder carcinoma: For example, METTL1 is associated with poor prognosis in bladder cancer, and it regulates the translation of EGFR/EFEMP1 by modifying certain tRNAs to inhibit the proliferation, migration and invasion of bladder cancer cells (7).